Bovie Medical PE Ratio 2006-2020 | APYX

Current and historical p/e ratio for Bovie Medical (APYX) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bovie Medical PE ratio as of May 29, 2020 is 0.00.
Bovie Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-05-29 4.44 0.00
2020-03-31 3.59 $-0.42 0.00
2019-12-31 8.46 $-0.56 0.00
2019-09-30 6.77 $-0.52 0.00
2019-06-30 6.72 $1.59 4.23
2019-03-31 6.31 $1.71 3.69
2018-12-31 6.48 $1.82 3.56
2018-09-30 7.10 $1.91 3.72
2018-06-30 4.35 $-0.11 0.00
2018-03-31 2.97 $-0.14 0.00
2017-12-31 2.60 $-0.17 0.00
2017-09-30 3.38 $-0.18 0.00
2017-06-30 2.47 $-0.18 0.00
2017-03-31 2.67 $-0.16 0.00
2016-12-31 3.59 $-0.17 0.00
2016-09-30 5.21 $-0.18 0.00
2016-06-30 1.64 $-0.20 0.00
2016-03-31 1.67 $-0.24 0.00
2015-12-31 2.10 $0.40 5.25
2015-09-30 1.95 $0.06 32.50
2015-06-30 2.79 $-0.05 0.00
2015-03-31 2.39 $-0.06 0.00
2014-12-31 3.68 $-1.18 0.00
2014-09-30 3.99 $-0.93 0.00
2014-06-30 3.63 $-0.78 0.00
2014-03-31 3.90 $-0.77 0.00
2013-12-31 2.15 $-0.24 0.00
2013-09-30 2.82 $-0.08 0.00
2013-06-30 2.95 $-0.06 0.00
2013-03-31 3.30 $0.01 0.00
2012-12-31 2.42 $0.04 60.50
2012-09-30 3.60 $-0.03 0.00
2012-06-30 2.39 $-0.03 0.00
2012-03-31 2.70 $-0.02 0.00
2011-12-31 2.12 0 0.00
2011-09-30 2.92 $-0.03 0.00
2011-06-30 2.61 $-0.03 0.00
2011-03-31 3.10 $-0.05 0.00
2010-12-31 3.28 $-0.09 0.00
2010-09-30 2.16 $-0.01 0.00
2010-06-30 2.98 $-0.01 0.00
2010-03-31 6.25 0 0.00
2009-12-31 7.81 $0.03 260.33
2009-09-30 7.85 $0.03 261.67
2009-06-30 8.71 $0.05 174.20
2009-03-31 6.60 $0.12 55.00
2008-12-31 6.24 $0.11 56.73
2008-09-30 6.84 $0.13 52.63
2008-06-30 7.15 $0.14 51.07
2008-03-31 6.40 $0.12 53.33
2007-12-31 6.40 $0.14 45.71
2007-09-30 7.00 $0.14 49.98
2007-06-30 6.02 $0.16 37.63
2007-03-31 7.10 $0.14 50.71
2006-12-31 9.07 $0.15 60.47
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.152B $0.028B
Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.899B 29.12
Medtronic (MDT) Ireland $132.114B 21.48
Stryker (SYK) United States $73.365B 23.81
Boston Scientific (BSX) United States $53.161B 24.99
Baxter (BAX) United States $45.654B 0.00
Lonza Group Ag (LZAGY) Switzerland $36.676B 0.00
Terumo (TRUMY) Japan $29.978B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.400B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.077B 16.41
ResMed (RMD) United States $23.266B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $17.849B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.566B 66.31
Insulet (PODD) United States $11.896B 1178.56
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Perrigo (PRGO) Ireland $7.466B 13.36
Quidel (QDEL) United States $7.350B 57.76
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Hill-Rom Holdings (HRC) United States $6.767B 19.08
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 0.00
Canopy Growth (CGC) Canada $6.093B 0.00
Haemonetics (HAE) United States $5.517B 33.14
ICU Medical (ICUI) United States $4.159B 30.34
GW Pharmaceuticals (GWPH) United Kingdom $3.796B 0.00
Neogen (NEOG) United States $3.754B 63.59
Agios Pharmaceuticals (AGIO) United States $3.564B 0.00
Envista Holdings (NVST) United States $3.366B 0.00
NuVasive (NUVA) United States $3.106B 24.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.909B 0.00
National Vision Holdings (EYE) United States $2.150B 37.19
TG Therapeutics (TGTX) United States $2.055B 0.00
AtriCure (ATRC) United States $1.916B 0.00
Aurora Cannabis (ACB) Canada $1.428B 0.00
Cardiovascular Systems (CSII) United States $1.366B 0.00
NanoString Technologies (NSTG) United States $1.152B 0.00
Aphria (APHA) Canada $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.060B 21.13
Cerus (CERS) United States $1.020B 0.00
MacroGenics (MGNX) United States $0.945B 0.00
InMode (INMD) Israel $0.937B 19.80
OraSure Technologies (OSUR) United States $0.902B 181.75
PetIQ (PETQ) United States $0.871B 25.15
Omeros (OMER) United States $0.811B 0.00
Quanterix (QTRX) United States $0.781B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.735B 0.00
VAREX IMAGING (VREX) United States $0.734B 18.21
Eagle Pharmaceuticals (EGRX) United States $0.702B 50.26
Meridian Bioscience (VIVO) United States $0.662B 24.93
Zynex (ZYXI) United States $0.644B 64.67
Vapotherm (VAPO) United States $0.567B 0.00
Lantheus Holdings (LNTH) United States $0.546B 10.98
LeMaitre Vascular (LMAT) United States $0.543B 30.91
Surmodics (SRDX) United States $0.503B 60.62
Owens & Minor (OMI) United States $0.500B 13.22
Repro-Med Systems (KRMD) United States $0.402B 337.33
Cytosorbents (CTSO) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.362B 26.32
BioLife Solutions (BLFS) United States $0.336B 149.54
Viemed Healthcare (VMD) United States $0.321B 28.72
Organigram Holdings (OGI) Canada $0.306B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.283B 0.00
HEXO (HEXO) $0.258B 0.00
Female Health (VERU) United States $0.247B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Chembio Diagnostics (CEMI) United States $0.169B 0.00
Evolus (EOLS) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 13.66
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.145B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.127B 0.00
MTech Acquisition (KERN) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.109B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
United-Guardian (UG) United States $0.072B 16.77
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00